These findings underscore the need for further research in radiotracer development with tumor specificity and the ability for multiple imaging time points, combined with a further understanding of PD-L1 biology and image analyses for successful PD-L1 imaging implementation in cancer. The gene discussed is CD274; the disease is cancer.